March 2022

In mid-February 2022, American Health Associates, Inc. (AHA) reached an agreement with the United States Department of Justice…

On February 12, 2021, the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent a…

On February 23, 2022, the United States District Court for the Central District of California denied Medtronic’s motion to dismiss…

Recently, Mallinckrodt ARD LLC reached a $260 million settlement to resolve allegations that Mallinckrodt violated the False…

Earlier this year, Connecticut Governor Ned Lamont proposed to set a maximum price on prescription drugs, drawing criticism from…

Despite significant improvement in the treatment of HER2-positive metastatic breast cancer in recent years, breast cancer remains…

Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…

On February 11, 2022, the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent a…

We have written several times on the December 2020 letter issued by the United States Department of Health and Human Services…

In light of the Coronavirus (COVID-19) pandemic, the Centers for Medicare and Medicaid Services (CMS) has been implementing…